log update
Browse files
log.txt
CHANGED
|
@@ -141653,3 +141653,216 @@ seed_type=wikitext | structural=PASS
|
|
| 141653 |
]
|
| 141654 |
}
|
| 141655 |
======================================================================
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 141653 |
]
|
| 141654 |
}
|
| 141655 |
======================================================================
|
| 141656 |
+
|
| 141657 |
+
======================================================================
|
| 141658 |
+
[GENERATE] atlas-6327900cd4 | 2026-08-17 22:53:36
|
| 141659 |
+
seed_type=wikitext | structural=PASS
|
| 141660 |
+
----------------------------------------------------------------------
|
| 141661 |
+
{
|
| 141662 |
+
"task_instruction": "Identify the key focus of the WHO 2008 classification of acute myeloid leukemia compared to the FAB criteria.",
|
| 141663 |
+
"steps": [
|
| 141664 |
+
{
|
| 141665 |
+
"observation": "The passage mentions that the WHO 2008 classification aims to be more clinically useful.",
|
| 141666 |
+
"reasoning": "This suggests that the primary goal is to improve the practical application of the classification system.",
|
| 141667 |
+
"action": "Identify the main purpose of the WHO classification."
|
| 141668 |
+
},
|
| 141669 |
+
{
|
| 141670 |
+
"observation": "It also states that the classification provides more meaningful prognostic information.",
|
| 141671 |
+
"reasoning": "This means that the focus is on offering better predictions about the course and outcome of the disease.",
|
| 141672 |
+
"action": "Determine the prognostic aspects emphasized by the WHO system."
|
| 141673 |
+
},
|
| 141674 |
+
{
|
| 141675 |
+
"observation": "The passage notes that the WHO categories include numerous descriptive subcategories for specialists.",
|
| 141676 |
+
"reasoning": "While these subcategories are detailed, the clinically significant information is conveyed through the subtypes listed in the schema.",
|
| 141677 |
+
"action": "Recognize the emphasis on subtypes for clinical communication."
|
| 141678 |
+
}
|
| 141679 |
+
]
|
| 141680 |
+
}
|
| 141681 |
+
</think>
|
| 141682 |
+
|
| 141683 |
+
```json
|
| 141684 |
+
{
|
| 141685 |
+
"task_instruction": "Determine the primary goal and focus of the WHO 2008 classification of acute myeloid leukemia compared to the FAB criteria.",
|
| 141686 |
+
"steps": [
|
| 141687 |
+
{
|
| 141688 |
+
"observation": "The passage states that the WHO 2008 classification aims to be more clinically useful.",
|
| 141689 |
+
"reasoning": "This implies that the primary focus is on enhancing practical application in clinical settings.",
|
| 141690 |
+
"action": "Identify the main objective of the WHO classification."
|
| 141691 |
+
},
|
| 141692 |
+
{
|
| 141693 |
+
"observation": "It also mentions that the classification provides more meaningful prognostic information.",
|
| 141694 |
+
"reasoning": "This indicates that predicting disease course and outcomes is a key aspect of the WHO system.",
|
| 141695 |
+
"action": "Determine the prognostic emphasis of the WHO criteria."
|
| 141696 |
+
},
|
| 141697 |
+
{
|
| 141698 |
+
"observation": "The passage notes that the WHO categories include numerous descriptive subcategories for specialists.",
|
| 141699 |
+
"reasoning": "While detailed, the clinically significant information is communicated through the listed subtypes, suggesting a focus on clear communication of subtypes for clinical use.",
|
| 141700 |
+
"action": "Recognize the importance of subtypes in clinical communication."
|
| 141701 |
+
}
|
| 141702 |
+
]
|
| 141703 |
+
}
|
| 141704 |
+
```
|
| 141705 |
+
======================================================================
|
| 141706 |
+
|
| 141707 |
+
======================================================================
|
| 141708 |
+
[GENERATE] atlas-10df854419 | 2026-08-17 22:54:14
|
| 141709 |
+
seed_type=wikitext | structural=PASS
|
| 141710 |
+
----------------------------------------------------------------------
|
| 141711 |
+
{
|
| 141712 |
+
"task_instruction": "Determine the classification of acute leukemias based on the presence of myeloid and lymphoid cells.",
|
| 141713 |
+
"steps": [
|
| 141714 |
+
{
|
| 141715 |
+
"observation": "The passage discusses acute leukemias of ambiguous lineage.",
|
| 141716 |
+
"reasoning": "These leukemias are called mixed phenotype or biphenotypic because they can't be classified as either myeloid or lymphoid.",
|
| 141717 |
+
"action": "Identify the terms used to describe this classification."
|
| 141718 |
+
},
|
| 141719 |
+
{
|
| 141720 |
+
"observation": "Both myeloid and lymphoid cells may be present in these leukemias.",
|
| 141721 |
+
"reasoning": "This means the classification is challenging because the cells don't fit neatly into one category.",
|
| 141722 |
+
"action": "Determine the appropriate classification based on cell presence."
|
| 141723 |
+
}
|
| 141724 |
+
]
|
| 141725 |
+
}
|
| 141726 |
+
</think>
|
| 141727 |
+
|
| 141728 |
+
{
|
| 141729 |
+
"task_instruction": "Classify acute leukemias based on the presence of myeloid and lymphoid cells.",
|
| 141730 |
+
"steps": [
|
| 141731 |
+
{
|
| 141732 |
+
"observation": "The passage describes a specific type of acute leukemia.",
|
| 141733 |
+
"reasoning": "It's known as acute leukemias of ambiguous lineage because the cells can't be classified as either myeloid or lymphoid.",
|
| 141734 |
+
"action": "Recognize the classification terms used."
|
| 141735 |
+
},
|
| 141736 |
+
{
|
| 141737 |
+
"observation": "Both myeloid and lymphoid cells may be present in these cases.",
|
| 141738 |
+
"reasoning": "This makes classification difficult as they don't fit into a single category.",
|
| 141739 |
+
"action": "Determine the appropriate classification based on cell types present."
|
| 141740 |
+
}
|
| 141741 |
+
]
|
| 141742 |
+
}
|
| 141743 |
+
======================================================================
|
| 141744 |
+
|
| 141745 |
+
======================================================================
|
| 141746 |
+
[GENERATE] atlas-935c36b19f | 2026-08-17 22:54:54
|
| 141747 |
+
seed_type=wikitext | structural=PASS
|
| 141748 |
+
----------------------------------------------------------------------
|
| 141749 |
+
{
|
| 141750 |
+
"task_instruction": "Understand the differences and uses of the FAB and WHO classification systems for AML.",
|
| 141751 |
+
"steps": [
|
| 141752 |
+
{
|
| 141753 |
+
"observation": "The passage mentions the FAB classification system divides AML into eight subtypes (M0 to M7).",
|
| 141754 |
+
"reasoning": "This is based on the type of cell and its maturity, determined through light microscopy and cytogenetics.",
|
| 141755 |
+
"action": "Identify the key components of the FAB system."
|
| 141756 |
+
},
|
| 141757 |
+
{
|
| 141758 |
+
"observation": "It also states that the WHO classification may be more useful.",
|
| 141759 |
+
"reasoning": "Despite this, the FAB system is still widely used, indicating both have their applications.",
|
| 141760 |
+
"action": "Compare the utility of FAB and WHO systems."
|
| 141761 |
+
}
|
| 141762 |
+
]
|
| 141763 |
+
}
|
| 141764 |
+
</think>
|
| 141765 |
+
|
| 141766 |
+
{
|
| 141767 |
+
"task_instruction": "Understand the differences and uses of the FAB and WHO classification systems for AML.",
|
| 141768 |
+
"steps": [
|
| 141769 |
+
{
|
| 141770 |
+
"observation": "The passage mentions the FAB classification system divides AML into eight subtypes (M0 to M7).",
|
| 141771 |
+
"reasoning": "This is based on the type of cell and its maturity, determined through light microscopy and cytogenetics.",
|
| 141772 |
+
"action": "Identify the key components of the FAB system."
|
| 141773 |
+
},
|
| 141774 |
+
{
|
| 141775 |
+
"observation": "It also states that the WHO classification may be more useful.",
|
| 141776 |
+
"reasoning": "Despite this, the FAB system is still widely used, indicating both have their applications.",
|
| 141777 |
+
"action": "Compare the utility of FAB and WHO systems."
|
| 141778 |
+
}
|
| 141779 |
+
]
|
| 141780 |
+
}
|
| 141781 |
+
======================================================================
|
| 141782 |
+
|
| 141783 |
+
======================================================================
|
| 141784 |
+
[GENERATE] atlas-1b1c8ff730 | 2026-08-17 22:55:49
|
| 141785 |
+
seed_type=wikitext | structural=PASS
|
| 141786 |
+
----------------------------------------------------------------------
|
| 141787 |
+
{
|
| 141788 |
+
"task_instruction": "Understand the progression from normal myeloblast to AML",
|
| 141789 |
+
"steps": [
|
| 141790 |
+
{
|
| 141791 |
+
"observation": "A myeloblast is an immature precursor of myeloid white blood cells.",
|
| 141792 |
+
"reasoning": "In normal conditions, myeloblasts mature into white blood cells, but in AML, they don't.",
|
| 141793 |
+
"action": "Identify the normal and abnormal states of myeloblasts."
|
| 141794 |
+
},
|
| 141795 |
+
{
|
| 141796 |
+
"observation": "AML myeloblasts accumulate genetic changes that prevent differentiation.",
|
| 141797 |
+
"reasoning": "These genetic changes cause the cells to remain immature, which is called differentiation arrest.",
|
| 141798 |
+
"action": "Recognize the role of genetic mutations in AML progression."
|
| 141799 |
+
},
|
| 141800 |
+
{
|
| 141801 |
+
"observation": "Other mutations disrupt proliferation controls, leading to uncontrolled growth.",
|
| 141802 |
+
"reasoning": "Combining differentiation arrest with mutations in proliferation genes causes leukemia.",
|
| 141803 |
+
"action": "Understand the dual mutation process in AML development."
|
| 141804 |
+
}
|
| 141805 |
+
]
|
| 141806 |
+
}
|
| 141807 |
+
</think>
|
| 141808 |
+
|
| 141809 |
+
{
|
| 141810 |
+
"task_instruction": "Determine the factors contributing to the development of AML from myeloblasts",
|
| 141811 |
+
"steps": [
|
| 141812 |
+
{
|
| 141813 |
+
"observation": "Myeloblasts are immature precursors of myeloid white blood cells.",
|
| 141814 |
+
"reasoning": "In normal cases, these cells mature into white blood cells, but in AML, this process is halted.",
|
| 141815 |
+
"action": "Identify the normal and abnormal maturation processes of myeloblasts."
|
| 141816 |
+
},
|
| 141817 |
+
{
|
| 141818 |
+
"observation": "Genetic changes cause myeloblasts to stop differentiating.",
|
| 141819 |
+
"reasoning": "This differentiation arrest keeps the cells in an immature state, which is a key step in AML development.",
|
| 141820 |
+
"action": "Understand the role of genetic mutations in halting differentiation."
|
| 141821 |
+
},
|
| 141822 |
+
{
|
| 141823 |
+
"observation": "Other mutations affect cell proliferation.",
|
| 141824 |
+
"reasoning": "When combined with differentiation arrest, these mutations lead to uncontrolled cell growth, resulting in AML.",
|
| 141825 |
+
"action": "Analyze the combined effect of different mutations on leukemia development."
|
| 141826 |
+
}
|
| 141827 |
+
]
|
| 141828 |
+
}
|
| 141829 |
+
======================================================================
|
| 141830 |
+
|
| 141831 |
+
======================================================================
|
| 141832 |
+
[GENERATE] atlas-28db2d0ca0 | 2026-08-17 22:56:25
|
| 141833 |
+
seed_type=wikitext | structural=PASS
|
| 141834 |
+
----------------------------------------------------------------------
|
| 141835 |
+
{
|
| 141836 |
+
"task_instruction": "Understand the relationship between the stage of differentiation and the characteristics of AML.",
|
| 141837 |
+
"steps": [
|
| 141838 |
+
{
|
| 141839 |
+
"observation": "AML's diversity arises from leukemic transformation at various differentiation stages.",
|
| 141840 |
+
"reasoning": "Differentiation stages play a key role in the heterogeneity of AML.",
|
| 141841 |
+
"action": "Recognize that the stage of differentiation affects the behavior and characteristics of AML."
|
| 141842 |
+
},
|
| 141843 |
+
{
|
| 141844 |
+
"observation": "Modern classification schemes focus on the leukemic cell's characteristics and behavior.",
|
| 141845 |
+
"reasoning": "Understanding the halted differentiation stage helps in categorizing AML cases.",
|
| 141846 |
+
"action": "Identify how the halted stage influences the classification of AML."
|
| 141847 |
+
}
|
| 141848 |
+
]
|
| 141849 |
+
}
|
| 141850 |
+
|
| 141851 |
+
</think>
|
| 141852 |
+
|
| 141853 |
+
{
|
| 141854 |
+
"task_instruction": "Understand how the stage of differentiation affects the classification and characteristics of AML.",
|
| 141855 |
+
"steps": [
|
| 141856 |
+
{
|
| 141857 |
+
"observation": "AML's diversity arises from leukemic transformation at various differentiation stages.",
|
| 141858 |
+
"reasoning": "Differentiation stages influence the heterogeneity of AML.",
|
| 141859 |
+
"action": "Recognize the impact of differentiation stages on AML's diversity."
|
| 141860 |
+
},
|
| 141861 |
+
{
|
| 141862 |
+
"observation": "Modern classification schemes focus on the leukemic cell's characteristics and behavior.",
|
| 141863 |
+
"reasoning": "Understanding the halted stage helps in categorizing AML cases.",
|
| 141864 |
+
"action": "Identify how the halted stage influences the classification of AML."
|
| 141865 |
+
}
|
| 141866 |
+
]
|
| 141867 |
+
}
|
| 141868 |
+
======================================================================
|